Results 181 to 190 of about 5,691,277 (301)

Medical Cannabis as an Opiate Alternative: A Prospective Observational Cohort Study. [PDF]

Cureus
Caldera FE, Caldera Z, Shofer F, Abramoff B, Lenrow D, Hampton S, Popescu A, Dillingham T.   +7 more
europepmc   +1 more source

Marketing features of derived intoxicating cannabinoid product brands on Instagram: A content analysis

Addiction, EarlyView.
Abstract Background and aims Use of derived intoxicating cannabinoid products (DICPs) has grown in the United States (US), as have associated poisonings, emergency department visits and psychotic episodes. Brand marketing on social media, a largely underregulated marketing channel, may be contributing to this growth.
Kathryn La Capria, Siyan Meng, Alisa A. Padon, Kayla K. Tillett, Scott I. Donaldson, Jon‐Patrick Allem, Matthew E. Rossheim, Cassidy LoParco, Carla J. Berg, Kristina M. Jackson, Julia Chen‐Sankey   +10 more
wiley   +1 more source

Cannabis-Based Medicinal Products for Endometriosis: A 2-Year Prospective Analysis From the UK Medical Cannabis Registry. [PDF]

Aust N Z J Obstet Gynaecol
Ahmed T, Erridge S, Clarke E, McLachlan K, Coomber R, Barnes S, Medniuk AD, Guru R, Holden W, Sajad M, Searle R, Usmani A, Rucker JJ, Platt M, Sodergren MH.   +14 more
europepmc   +1 more source

Towards the implementation of cannabis‐focused apps in early intervention services for psychosis: A qualitative investigation of patient and clinician perspectives

Addiction, EarlyView.
Abstract Background and aims Cannabis use is highly prevalent among young adults with first‐episode psychosis (FEP) and is associated with poorer clinical and functional outcomes. Mobile health interventions may help address structural barriers to delivering cannabis‐focused psychosocial interventions within early intervention services (EIS), yet ...
Selim Abou‐Rahal, Alexis Doucet, Pamela Lachance‐Touchette, Amal Abdel‐Baki, Stephanie Coronado‐Montoya, José Côté, Ovidiu Tatar, Philip G. Tibbo, Didier Jutras‐Aswad   +8 more
wiley   +1 more source

Knowledge, attitudes, and concerns about medical cannabis among U.S. healthcare professionals. [PDF]

J Cannabis Res
Kumar L, Wang E, Mathai DS, Zamarripa CA, Spindle TR, Vandrey R, Garcia-Romeu A.   +6 more
europepmc   +1 more source

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program

Addiction, EarlyView.
Abstract Background and aims Recovery capital and genetic liability may be related to substance use disorder (SUD) remission through psychosocial and biologic pathways, but their joint association with remission course remains poorly understood. This question is clinically important because people entering remission differ in recovery resources and ...
Janaka V. Kosgolla, Douglas C. Smith
wiley   +1 more source

UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine. [PDF]

Brain Behav
Hooper L, Erridge S, Clarke E, McLachlan K, Coomber R, Iqbal A, Rucker JJ, Weatherall MW, Sodergren MH.   +8 more
europepmc   +1 more source

Authorizing medical cannabis for children [PDF]

Paediatrics & Child Health, 2020
openaire   +3 more sources

Cannabis use and cannabis use disorder among older adults in the USA

Addiction, EarlyView.
Abstract Background and aims Cannabis use is increasing among older adults in the United States (US); however, little is known regarding details of use or cannabis use disorder (CUD) in this population. This study aimed to describe cannabis use and CUD among older adults in the US.
Benjamin H. Han, Evan L. Eschliman, Joseph J. Palamar, Mireia Triguero Roura, Pia M. Mauro   +4 more
wiley   +1 more source

Healthcare students' knowledge and attitude toward medical cannabis: a cross-sectional study in southeastern Iran. [PDF]

J Cannabis Res
Dehghan M, Behzadi Fard S, Najmadini A, Azizzadeh Forouzi M, Rabiei Vaziri M, Shahidizandi A.   +5 more
europepmc   +1 more source